Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2014-12-16 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Clinical Validation Supporting BREVAGenplus 2 pages 103.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 December 2014 from Genetic Technologies Limited. It discusses clinical validation study results supporting the use of their BREVAGen plus breast cancer risk assessment test. The content focuses on research findings, product launch updates, and strategic plans. There are no financial statements, regulatory filings, voting results, or management changes. The document is a corporate announcement about clinical study results and product validation, not a financial report or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or corporate update. Given the absence of a more specific category, the best fit is Regulatory Filings (RNS). The document length (7425 characters) and content confirm it is not a brief report publication announcement or a certification letter.
2014-12-16 English
BBY Initiates Coverage - 27 11 2014 1 page 119.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 December 2014, titled 'BBY Initiates Coverage'. It states that BBY has published a research report on the company dated 27 November 2014 and provides a link to view that report. The document is short (2894 characters) and primarily serves to announce the initiation of coverage by an external research firm, not to present any financial data or detailed company reports. There are no financial statements, management discussion, or regulatory filings included. The content is consistent with a Regulatory Filing (RNS) as it is a general announcement that does not fit into other specific categories such as Annual Report, Earnings Release, or Investor Presentation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-12-07 English
Share Purchase Plan documents 11 pages 252.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 5 December 2014 regarding the release of Share Purchase Plan (SPP) documents by Genetic Technologies Limited. It includes details about the SPP offer, application forms, pricing, and terms for shareholders to purchase new shares. The content focuses on the announcement and provision of documents related to a capital raising activity, specifically a share purchase plan. There is no detailed financial report or analysis, nor is it a transcript, management report, or regulatory filing unrelated to capital raising. The document is not a full financial report but an announcement and provision of offer documents related to a financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2014-12-04 English
Appendix 3B 12 pages 109.9KB
Regulatory Filings
2014-12-04 English
Share Purchase Plan - Cleansing Notice 2 pages 121.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 December 2014 regarding a Share Purchase Plan (SPP) cleansing notice. It discusses the company's intention to offer new shares to eligible shareholders and compliance with ASIC Class Order CO 09/425 and Corporations Act provisions. The content focuses on the announcement of a capital raising activity (share purchase plan) and related regulatory compliance notices. There are no financial statements, earnings data, or detailed management discussion. The document is relatively short (4260 characters) and serves as a formal announcement of a financing event rather than a full report or detailed financial disclosure. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2014-12-03 English
Proposed Share Purchase Plan (SPP) 2 pages 128.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 3 December 2014 from Genetic Technologies Limited regarding a proposed Share Purchase Plan (SPP) to raise capital. It details the terms of the SPP, including the price, discount, record date, and intended use of funds. The content focuses on fundraising and capital management activities rather than financial results, management changes, or regulatory filings. There is no indication that this is a full financial report or an earnings release. The document is a formal announcement about a capital raising initiative, which fits the definition of a Capital/Financing Update (CAP). The document length is 4713 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2014-12-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.